Table 1 Clinical and laboratory findings of the patients showing a discrepancy between the log reduction method and the IS method.
a)≥1 log10 reduction at 3 months was considered as EMR.
b)≤10% IS at 3 months was considered as EMR.
Abbreviations: CML-CP, chronic myeloid leukemia in chronic phase; EMR, early molecular response; IS, international scale.